Log in or Sign up for Free to view tailored content for your specialty!
Psychiatry News
Risks faced by some pregnant Medicaid enrollees highlight need for adequate postnatal care
The rates of opioid use disorder among pregnant people enrolled in Medicaid may be twice as high as prior estimates, according to a recent cross-sectional analysis published in JAMA Network Open.
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS.
Q&A: Coffee, tea may impact memory, cognition, motor function related to Alzheimer’s
Consumption of certain teas and coffee may have positive effects on neural network maintenance that could bode well for the prevention of symptoms indicative of Alzheimer’s disease, according to research published in Nutrients.
Log in or Sign up for Free to view tailored content for your specialty!
Higher red meat intake increases risk for cognitive decline, dementia
Higher consumption of red meat, including processed red meat, was associated with a higher risk for cognitive decline and dementia, according to research published in Neurology.
Machine-learning method detects REM sleep behavior disorder with nearly 92% accuracy
An automated machine-learning method that analyzed sleep movements recorded with a conventional 2D camera may improve diagnosis of rapid eye movement sleep behavior disorder, according to a study published in Annals of Neurology.
Experts ID best screening tool, treatments for OCD in children
Researchers identified the most effective screening tools and treatment options for children with obsessive compulsive disorder, according to the results of two meta-analyses published in Pediatrics.
FDA proposes cap on nicotine levels in cigarettes
The FDA has proposed limiting the level of nicotine in cigarettes and other combusted tobacco products like cigars and pipe tobacco to make them “minimally or nonaddictive,” according to a press release from the agency.
FDA grants biologics license application for monthly IV Leqembi
The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat individuals with mild cognitive impairment or mild dementia consistent with early stage Alzheimer’s disease.
Life and umbrella insurance: Life can change quickly
As physicians, we have all borne witness to patients dying at a young age, whether from an unforeseen illness or injury.
FDA grants fast-track designation to small molecule for Fragile X
The FDA has granted fast-track designation to an investigational small molecule to treat individuals with Fragile X syndrome, according to the manufacturer.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read